Drug for Overactive Bladder Recommended in Europe
Obgemsa is suitable for treating symptoms of an overactive bladder in adults, the European Medicines Agency has determined.
Stay updated with breaking news from Urinary Bladder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Obgemsa is suitable for treating symptoms of an overactive bladder in adults, the European Medicines Agency has determined.
Raj Thackeray's political trajectory reflects strategic shifts from regional to national issues, aiming to establish MNS as a key player in Maharashtr
A deforming birth defect has a devastating psychological impact upon the child's parents, and has the potential for life-long impact upon the physical, psychological and socio-economic well-being of the child.
Interim findings from the ongoing AMBASSADOR trial revealed a significant DFS benefit with adjuvant pembrolizumab but no overall survival benefit at this point.
Active surveillance is safe and improves quality of life but requires careful patient selection and relevant follow-up, said one expert.